{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:25:21Z","timestamp":1791181521473,"version":"4.1.0"},"reference-count":32,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2013,11,26]],"date-time":"2013-11-26T00:00:00Z","timestamp":1385424000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2014,3]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Follicular Lymphoma (<jats:styled-content style=\"fixed-case\">FL<\/jats:styled-content>) is the second most common non\u2010Hodgkin lymphoma (<jats:styled-content style=\"fixed-case\">NHL<\/jats:styled-content>) subtype and its course is heterogeneous. At diagnosis, some patients with <jats:styled-content style=\"fixed-case\">FL<\/jats:styled-content> manifest a detectable leukaemic phase (<jats:styled-content style=\"fixed-case\">FL<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">LP<\/jats:styled-content>), but this feature has been seldom described and is poorly characterized. Among 499 patients diagnosed with <jats:styled-content style=\"fixed-case\">FL<\/jats:styled-content> in Lyon\u2010Sud hospital, 37 (7\u00b74%) had characteristic <jats:styled-content style=\"fixed-case\">FL<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">LP<\/jats:styled-content> (by cytological blood smears and flow cytometric analysis). In addition, 91\/1135 <jats:styled-content style=\"fixed-case\">FL<\/jats:styled-content> patients from the <jats:styled-content style=\"fixed-case\">PRIMA<\/jats:styled-content> study presented <jats:styled-content style=\"fixed-case\">FL<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">LP<\/jats:styled-content> at study entry. In order to evaluate the outcome of this Lyon\u2010Sud cohort, <jats:styled-content style=\"fixed-case\">FL<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">LP<\/jats:styled-content> patients were matched with 111 newly diagnosed <jats:styled-content style=\"fixed-case\">FL<\/jats:styled-content> without <jats:styled-content style=\"fixed-case\">LP<\/jats:styled-content> according to the Follicular Lymphoma International Prognostic Index (<jats:styled-content style=\"fixed-case\">FLIPI<\/jats:styled-content>) score, age and treatment. Presence of <jats:styled-content style=\"fixed-case\">FL<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">LP<\/jats:styled-content> was associated with shorter progression\u2010free survival (<jats:styled-content style=\"fixed-case\">PFS<\/jats:styled-content>) and overall survival (<jats:styled-content style=\"fixed-case\">OS<\/jats:styled-content>) (<jats:italic>P<\/jats:italic>\u00a0=\u00a00\u00b7004 and <jats:italic>P<\/jats:italic>\u00a0=\u00a00\u00b7031, respectively). Presence of <jats:styled-content style=\"fixed-case\">FL<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">LP<\/jats:styled-content> and high <jats:styled-content style=\"fixed-case\">FLIPI<\/jats:styled-content> score remained independent prognostic factors in a Cox model for time to progression (<jats:styled-content style=\"fixed-case\">TTP<\/jats:styled-content>). A number of circulating lymphoma cells (<jats:styled-content style=\"fixed-case\">CLC<\/jats:styled-content>) &gt;4\u00a0\u00d7\u00a010<jats:sup>9<\/jats:sup>\/l was the most significant predictor for a shorter <jats:styled-content style=\"fixed-case\">TTP<\/jats:styled-content> in this Cox model. The prognostic impact of <jats:styled-content style=\"fixed-case\">FL<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">LP<\/jats:styled-content> on <jats:styled-content style=\"fixed-case\">TTP<\/jats:styled-content> was validated in the <jats:styled-content style=\"fixed-case\">PRIMA<\/jats:styled-content> cohort (<jats:italic>P<\/jats:italic>\u00a0=\u00a00\u00b70004). In conclusion, <jats:styled-content style=\"fixed-case\">FL<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">LP<\/jats:styled-content> is a rare event associated with shorter <jats:styled-content style=\"fixed-case\">PFS<\/jats:styled-content> and patients with <jats:styled-content style=\"fixed-case\">CLC<\/jats:styled-content> &gt;4\u00a0\u00d7\u00a010<jats:sup>9<\/jats:sup>\/l have a poorer outcome. These patients should be monitored carefully to consider alternative therapeutic options.<\/jats:p>","DOI":"10.1111\/bjh.12675","type":"journal-article","created":{"date-parts":[[2013,11,26]],"date-time":"2013-11-26T09:39:29Z","timestamp":1385458769000},"page":"659-667","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Peripheral blood involvement in patients with follicular lymphoma: a rare disease manifestation associated with poor prognosis"],"prefix":"10.1111","volume":"164","author":[{"given":"Cl\u00e9mentine","family":"Sarkozy","sequence":"first","affiliation":[{"name":"Hospices Civils de Lyon (HCL) Service d'H\u00e9matologie Centre Hospitalier Lyon Sud (CHLS) Pierre Benite Cedex France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucile","family":"Baseggio","sequence":"additional","affiliation":[{"name":"HCL Service d'h\u00e9matologie biologique CHLS Pierre Benite Cedex France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Feugier","sequence":"additional","affiliation":[{"name":"CHU de Nancy Universit\u00e9 de Lorraine Nancy France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyne","family":"Callet\u2010Bauchu","sequence":"additional","affiliation":[{"name":"HCL Service d'h\u00e9matologie biologique unit\u00e9 de cytog\u00e9n\u00e9tique CHLS Pierre Benite Cedex France"},{"name":"Universit\u00e9 Lyon1 Lyon France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Karlin","sequence":"additional","affiliation":[{"name":"Hospices Civils de Lyon (HCL) Service d'H\u00e9matologie Centre Hospitalier Lyon Sud (CHLS) Pierre Benite Cedex France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Seymour","sequence":"additional","affiliation":[{"name":"Peter MacCallum Cancer Centre and University of Melbourne Melbourne Vic. Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Lebras","sequence":"additional","affiliation":[{"name":"Hospices Civils de Lyon (HCL) Service d'H\u00e9matologie Centre Hospitalier Lyon Sud (CHLS) Pierre Benite Cedex France"},{"name":"Universit\u00e9 Lyon1 Lyon France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne\u2010Sophie","family":"Michallet","sequence":"additional","affiliation":[{"name":"Hospices Civils de Lyon (HCL) Service d'H\u00e9matologie Centre Hospitalier Lyon Sud (CHLS) Pierre Benite Cedex France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fritz","family":"Offner","sequence":"additional","affiliation":[{"name":"Ghent University Ghent Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Dumas","sequence":"additional","affiliation":[{"name":"Hospices Civils de Lyon (HCL) Service d'H\u00e9matologie Centre Hospitalier Lyon Sud (CHLS) Pierre Benite Cedex France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Traverse\u2010Glehen","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Lyon1 Lyon France"},{"name":"HCL service d'Anatomie pathologique CHLS Pierre Benite Cedex France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Ffrench","sequence":"additional","affiliation":[{"name":"HCL service d'Anatomie pathologique CHLS Pierre Benite Cedex France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Lopez\u2010Guillermo","sequence":"additional","affiliation":[{"name":"Hospital Clinic Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Berger","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Lyon1 Lyon France"},{"name":"HCL service d'Anatomie pathologique CHLS Pierre Benite Cedex France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Coiffier","sequence":"additional","affiliation":[{"name":"Hospices Civils de Lyon (HCL) Service d'H\u00e9matologie Centre Hospitalier Lyon Sud (CHLS) Pierre Benite Cedex France"},{"name":"Universit\u00e9 Lyon1 Lyon France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Felman","sequence":"additional","affiliation":[{"name":"HCL Service d'h\u00e9matologie biologique CHLS Pierre Benite Cedex France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Salles","sequence":"additional","affiliation":[{"name":"Hospices Civils de Lyon (HCL) Service d'H\u00e9matologie Centre Hospitalier Lyon Sud (CHLS) Pierre Benite Cedex France"},{"name":"Universit\u00e9 Lyon1 Lyon France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,11,26]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2011.574753"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.6.1950"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.309.6962.1128"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401272"},{"key":"e_1_2_8_6_1","volume-title":"WHO Classification of tumors of haematopoietic and lymphoid tissues","author":"Campo E.","year":"2008"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.4.1244"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.2403"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1993.tb00149.x"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.6.1900"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.21.3991"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03256596"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0b013e32833d5938"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-08-370908"},{"key":"e_1_2_8_15_1","first-page":"1135","article-title":"CD44 expression during tumor progression of follicular lymphoma","volume":"22","author":"Higashi M.","year":"2009","journal-title":"Oncology Reports"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20555"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-09-238782"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.41.9.951"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2012.09209.x"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(01)00122-9"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1053\/S0046-8177(03)00410-6"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-12-400580"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2010.036277"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.1693"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-10-3907"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1385\/MO:23:1:131"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)62175-7"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2011.616611"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2006.06232.x"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199311253292203"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-12-4434"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.310.6975.329d"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-07-098848"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjh.12675","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.12675","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T14:52:36Z","timestamp":1696344756000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bjh.12675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,26]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["10.1111\/bjh.12675"],"URL":"https:\/\/doi.org\/10.1111\/bjh.12675","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,26]]},"assertion":[{"value":"2013-08-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-09-18","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-11-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}